Skip to content

Preventing falls and freezing in Parkinson�s Disease using a vibration based wearable device

Wearable based sensory cueing in Parkinsons disease: Effects on gait and freezing

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039256
Enrollment
50
Registered
2022-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: WALK: Vibration based wearable device for sensory cueing. Device will be worn for 50-60 minutes per session for 16 sessions. Control Intervention1: Shame device: Sham device for control

Sponsors

Lifespark Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants with idiopathic PD 2. Participants who are able to walk independently with or without aid 3. Participants who are moderately severe PD stage (Hoehn and Yahr Stage IIââ?¬â??IV), Patients reporting freezing of gait (according to FOGQ scale) 4. Mental State Examination (HMSE) ââ?°Â¥ 24 5. The participant is expected to remain available (geographically stable) for 2 months after enrollment.

Exclusion criteria

Exclusion criteria: 1. Any medical condition compromising the safety or the ability to take part to the study (such as insufficient vision or hearing, inability to participate in therapy session, inability to communicate, upper limb condition not linked to stroke, uncontrolled blood pressure, uncontrolled diabetes, co-morbidity) 2. Participants with coexisting serious chronic medical illnesses (e.g., orthopedic, psychiatric, or neurological), major depression, or dementia. 3. Participants with gait difficulty other than PD.

Design outcomes

Primary

MeasureTime frame
Change in FOG scale score, Percentage reduction in TUG test score, Percentage change in functional gait scoreTimepoint: 16 sessions, 16 sessions, 16 sessions

Secondary

MeasureTime frame
Device acceptance according to 5 point Likert scaleTimepoint: 16 sessions

Countries

India

Contacts

Public ContactDr Rajesh Benny

Fortis Hospital

rajeshbenny@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026